Try our Advanced Search for more refined results
Corporate
-
March 25, 2026
Mom Tying Abbott Formula To Baby's NEC Takes The Stand
A plaintiff claiming Abbott Laboratories' preterm baby formula contributed to her infant's development of a serious gut condition told an Illinois jury Wednesday that she wouldn't have allowed her baby to consume the formula had she known it increased the risk of the infection, saying her now-teenage daughter still struggles with medical complications as a result.
-
March 25, 2026
Estate Says OpenAI Suicide Suit Distinct From Murder Suit
The estate of a man who murdered his mother and died by suicide allegedly because of his use of ChatGPT is urging a California federal court not to dismiss its suit against OpenAI, saying the suit doesn't run parallel to a state court case from the mother's estate.
-
March 25, 2026
Lender Targets Borrower, Guarantor In $3.8M Default Suit
A Delaware lender has sued a group of real estate investors and affiliated entities in Delaware Chancery Court, accusing them of defaulting on a $3.8 million mezzanine loan and then diverting collateral to avoid repayment.
-
March 25, 2026
Turf Company Executive Can't Escape Trade Secrets Suit
An executive must face a turf manufacturer's suit claiming he took confidential information with him when he jumped ship for a rival company, a Georgia federal judge ruled, but said a lack of plausible misconduct allegations meant that rival should be dismissed from the case.
-
March 25, 2026
Ashurst Adds 4 Ex-Bracewell Partners To Finance Practice
Ashurst LLP has announced the addition of a four-partner team in New York to expand its finance and restructuring capacities ahead of a proposed merger with Perkins Coie LLP.
-
March 25, 2026
Judge Trims SEC Fraud Case Over Cancer Drug Claims
A Massachusetts federal judge greenlighted U.S. Securities and Exchange Commission claims against two of three former pharmaceutical executives accused of concealing from investors the U.S. Food and Drug Administration's "harsh critiques" about a cancer drug.
-
March 25, 2026
Insurer Need Not Cover Parkinson's Drug Antitrust Dispute
An insurer does not owe coverage in an antitrust suit accusing a pharmaceutical company of suppressing generic versions of the Parkinson's treatment Apokyn, a Maryland federal judge ruled, finding the dispute does not involve "securities claims" covered under the insurer's policy.
-
March 25, 2026
Del. Chancellor Pauses Tesla Suit As Musk Cites LinkedIn Post
The Delaware Chancery Court has paused a high-profile Tesla stockholder case following a recusal bid from Elon Musk and Tesla Inc. after a judge's LinkedIn account appeared to react to a post celebrating a recent California jury verdict against Musk, including language praising efforts to stand up to "the richest man in the world."
-
March 25, 2026
Utah Expands Unrelated Biz Income Definition For Corp. Tax
Utah will expand its definition of corporate income to include income allocated to the state under a bill signed by the state's governor.
-
March 25, 2026
Jury Doubles Damages Against Meta, Google In LA Bellwether
A California state jury that found Meta and Google liable Wednesday for harming the mental health of a woman who says she became addicted to their social media platforms as a child delivered a second blow later in the day, awarding $3 million in punitive damages on top of a $3 million compensatory award.
-
April 01, 2026
White & Case Expands In Brussels With Amazon Hire
White & Case LLP has recruited a senior in-house lawyer at Amazon for its office in Brussels, the law firm's latest technology-focused hire globally.
-
March 25, 2026
High Court Reverses Music Piracy Liability Ruling Against Cox
The U.S. Supreme Court on Wednesday said the Fourth Circuit incorrectly affirmed a jury verdict that found Cox Communications liable for its customers' music piracy, concluding there is a legal distinction between mere knowledge of infringement and intent to promote it.
-
March 24, 2026
Pentagon 'Punishing' Anthropic Would Be Illegal, Judge Says
A California federal judge considering Anthropic's request to block the U.S. Department of Defense from labeling it a supply chain national security risk said Tuesday that it looks like the government is "punishing" Anthropic for bringing public attention to their contract fight, a move that would violate the First Amendment.
-
March 24, 2026
Meta Tackles Borrowed Underwear Analogy In Privacy Suit
A California federal judge mulling Meta's argument that its users' consent bars a proposed privacy class action pressed Meta's lawyers Tuesday on whether social expectations affect the bounds of that consent, observing that if she gave a friend permission to borrow her clothes, "I don't expect her to borrow my underwear."
-
March 24, 2026
Iowa Asks 5th Circ. To Ax 'Uncertain' Schwab Antitrust Deal
Iowa's attorney general Monday pressed the Fifth Circuit to reject investors' deal with The Charles Schwab Corp. in an antitrust suit over its merger with TD Ameritrade, arguing it offers only uncertain and hypothetical relief to class members while giving named plaintiffs and class counsel a "windfall."
-
March 24, 2026
AI Tools May 'Disrobe' Meta Of Section 230 Shield, Judge Says
A California federal judge trimmed Tuesday a proposed class action alleging Meta Platforms Inc. knowingly participated in a Chinese pump-and-dump scheme advertised on social media, but found there's a factual dispute over whether Meta's AI tools materially contributed to the "facially ridiculous" ads.
-
March 24, 2026
FINRA CEO Highlights New Clearinghouse For Cyber Threats
Robert Cook, CEO of the Financial Industry Regulatory Authority, said Tuesday that it will soon be rolling out a clearinghouse for firms to report cybersecurity threats and to promote information sharing across the industry.
-
March 24, 2026
Drug Co. Atara Hit With Investor Suit Over FDA Denial
Drug company Atara Biotherapeutics Inc. has been hit with a proposed class action accusing it of harming investors by not disclosing certain manufacturing problems and research study deficiencies that made it unlikely the U.S. Food and Drug Administration would approve its new drug application.
-
March 24, 2026
Delaware Court Tosses Allied Gaming Suit, Awards $5.9M Fees
The Delaware Chancery Court on Tuesday dismissed a stockholder challenge to a disputed share issuance at Allied Gaming & Entertainment Inc. as moot, while ordering the company to pay nearly $5.94 million in attorney fees and expenses after finding that the litigation prompted the company to reverse course.
-
March 24, 2026
Sarepta Urges Full Fed. Circ. To Wipe Out Gene Therapy IP
Sarepta Therapeutics Inc. wants the full Federal Circuit to rethink a decision reviving a University of Pennsylvania gene therapy patent, saying a panel got its analysis of patent eligibility wrong.
-
March 24, 2026
Compliance Chiefs Offer Insight On AI In Financial Services
JPMorgan Chase & Co.'s chief compliance officer said Tuesday that artificial intelligence has proven "transformative" to her bank, and that she sees a time when compliance officers may come to supervise AI agents as the technology evolves.
-
March 24, 2026
Publishers Say Anthropic's Use Of Lyrics Violates Copyrights
Music publishers have asked a California federal judge to rule that Anthropic infringed their copyrighted song lyrics through its Claude large language model, arguing in a motion for partial summary judgment that fair use does not excuse the AI developer's conduct because it used those lyrics to build a competing commercial product.
-
March 24, 2026
Crypto Project Execs Escape Investors' Fraud, RICO Suit
A Tennessee federal judge has dismissed the alleged co-CEO and other executives of purported crypto projects from a suit accusing them of duping investors out of tens of millions of dollars with false promises of returns, finding the investors do not plausibly plead their fraud or racketeering claims.
-
March 24, 2026
Ga. Exec Cops To Role In Alleged $380M Ponzi Scheme
The former chief administrative officer of an Atlanta-area financial advisory group pled guilty Tuesday to one count of money laundering in connection to her role in what prosecutors said was a $380 million Ponzi scheme.
-
March 24, 2026
Meta Owes $375M In NM Trial Over Harm To Teens
A New Mexico jury said Tuesday that Meta must pay $375 million over the state attorney general's bellwether claims that the social media giant hid the full scope of mental health harm its apps were causing to underage users.
Expert Analysis
-
Autonomous AI Attacks Demarcate Shift In Risk Landscape
Anthropic and OpenAI recently disclosed cyberattacks where an artificial intelligence agent was the primary attacker, illustrating immediate implications for corporate governance, contracting and security programs as companies integrate AI with their business systems, say Rahul Mukhi and Melissa Faragasso at Cleary and Brian Lichter at Stroz Friedberg.
-
2025's Defining AI Securities Litigation
Three securities litigation decisions from 2025 — involving General Motors, GitLab and Tesla — offer a preview of how courts will assess artificial intelligence-related disclosures, as themes such as heightened regulatory scrutiny and risk surrounding technical claims are already taking shape for the coming year, say attorneys at Cooley.
-
How 11th Circ.'s Zafirov Decision Could Upend Qui Tam Cases
Oral argument before the Eleventh Circuit last month in U.S. ex rel. Zafirov v. Florida Medical Associates suggests that the court may affirm a lower court's opinion that the qui tam provisions of the False Claims Act are unconstitutional — which could wreak havoc on pending and future qui tam cases, say attorneys at Morgan Lewis.
-
Targeted Action, Rule Tweaks Reflect 2025 AML Priority Shifts
Though 2025’s anti-money-laundering landscape was characterized not by volume of penalties but by the strategic recalibration of how illicit finance risk is handled, a series of targeted enforcement actions signaled that regulators aren't easing off the accelerator, even as they refine the rules of the road, say attorneys at MoFo.
-
Series
Mass. Banking Brief: All The Notable Legal Updates In Q4
Among the most significant developments on the banking regulation front in Massachusetts last quarter, Attorney General Andrea Joy Campbell announced her bid for reelection, and the state Division of Banks continued its fintech focus by finalizing rules implementing a new money transmitter law, say attorneys at Nutter.
-
Series
Muay Thai Makes Me A Better Lawyer
Muay Thai kickboxing has taught me that in order to win, one must stick to one's game plan and adapt under pressure, just as when facing challenges by opposing counsel or judges, says Mark Schork at Feldman Shepherd.
-
Series
Law School's Missed Lessons: Intentional Career-Building
A successful legal career is built through intention: understanding expectations, assessing strengths honestly and proactively seeking opportunities to grow and cultivating relationships that support your development, say Erika Drous and Hillary Mann at Morrison Foerster.
-
Series
A Day In The In-House Life: Chime GC Talks Pathfinding
On a recent Tuesday in the office, Chime's general counsel Adam Frankel shares his typical work day, tackling everything from strategically guiding product launches and testing AI tools to mastering the perfect latte and making time for extracurricular interests.
-
How Shareholder Activism Fared In 2025
2025 was a turbulent yet transformative year in shareholder activism, and there are several key takeaways to help companies prepare for a 2026 that is shaping up to be even more lively, including increased focus on retail investors and the use of social media as a tool, say attorneys at Sidley.
-
Reviewing 2025's Artificial Intelligence Disputes Over IP
2025 brought the first major fair use rulings involving generative artificial intelligence, and in 2026 courts will weigh in on more discovery disputes, renewed motions to dismiss, class certification challenges and fair use defenses that could shape the course of future AI litigation, say attorneys at Debevoise.
-
Expect A New Normal In Commercial Real Estate This Year
Even amid office vacancies and a wave of loan maturities, the commercial real estate market isn't as volatile as one might expect heading into 2026, but market stress is still uniquely intersecting with broader business challenges, creating new opportunities for corporate counsel and other practitioners beyond real estate, says Mark Bell at Stinson.
-
Key Trends In Healthcare Antitrust In 2025
The healthcare industry braced for significant antitrust enforcement shifts last year driven by a change in administration, and understanding the implications of these trends is critical for healthcare organizations' risk management and strategic decision-making in the year ahead, say attorneys at Michael Best.
-
Preparing For Congressional Investigations In A Midterm Year
2026 will be a consequential year for congressional oversight as the upcoming midterm elections may yield bolder investigations and more aggressive state attorneys general coalitions, so companies should consider adopting risk management measures to get ahead of potential changes, say attorneys at Morgan Lewis.
-
Key Trends Shaping ESG And Sustainability Law In 2026
2025 saw a chaotic regulatory landscape and novel litigation around environmental, social and governance issues and sustainability — and 2026, while perhaps more predictable, will likely be no less challenging, with more lawsuits and a regulatory tug-of-war complicating compliance for global companies, say attorneys at Crowell.
-
How Bank M&A Prospects Brightened In 2025
Even with less-than-ideal macroeconomic conditions in 2025, federal banking regulators' shift away from procedural concerns to focus more on core financial risks boosted M&A in several key ways, including shorter review timelines and increased interest in de novo charters, say attorneys at Arnold & Porter.